DiaPharma
DiaPharma is a privately held US/Canadian specialty distributor of hemostasis, coagulation, liver disease, hematology, and biomarker assay kits and instruments from 18+ partner brands, serving clinical and research laboratories since 1997.
- Company typePrivate
- Founded1997
- HeadquartersWest Chester, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What DiaPharma does
DiaPharma Group, Inc. is a privately held specialty distributor of medical and laboratory diagnostic products headquartered in West Chester, Ohio. Founded on January 1, 1997 from Pharmacia Hepar, Inc., the company has operated continuously for over 25 years, distributing assay kits, bioreagents, chromogenic substrates, antibodies, and laboratory instruments exclusively in the United States and Canada. Its product portfolio spans seven core categories — hemostasis (365+ products), instruments, hematology, liver disease, fibrosis, NETosis research, and additional biomarkers — and is sourced from more than 18 partner manufacturers including Chromogenix, Technoclone, VLVbio/Peviva, Volition, Haematex, Zacros, QuickZyme, Rossix, Stasys, Teco Medical, Pplus, AroCell, BioTek, CMIC, Inter-Array, IQ Products, ProAxsis, and ImmunoDiagnostics. DiaPharma holds exclusive US and Canadian distribution rights for Chromogenix hemostasis and fibrinolysis products and additionally markets a proprietary DPG label (including the Fiix Factor VIII inhibitor testing line, DOAC-Stop anticoagulant neutralization products, INHIBIREF reference products, and Haematex-derived specialty reagents).
The business operates a hybrid go-to-market combining a three-territory direct field sales force (East, Midwest, West — covering all 50 US states and 11 Canadian provinces) with inside sales via phone, email, fax, and a website-based Quote Cart system. Pricing is quote-based and not publicly disclosed; first-time customers apply for NET30 credit terms or pay by credit card with a 3% processing fee. Distribution focuses on clinical and research laboratories in hemostasis/coagulation, liver disease research (MASH, ALD, DILI), oncology drug development (apoptosis detection), hematology research (sickle cell and fetomaternal hemorrhage), and additional biomarker fields such as fibrosis, NETosis, kidney injury, and diabetes. The company complements distribution with scientific content marketing — blog articles, webinars (often co-hosted with partner manufacturers such as Technoclone), and active participation in industry conferences including ISTH, ISLH, ASH, and AASLD — positioning expertise in hemostasis and coagulation as the primary differentiator from broader-line laboratory distributors.
Revenue mechanics are fundamentally those of a multi-brand specialty medical distributor: DiaPharma purchases finished goods, reagents, and instruments from partner manufacturers and resells them to North American clinical and research laboratories, capturing distribution margins on catalog products plus hardware margin on instruments such as the Ceveron s100, T-TAS01, and Atlas PST. Three US/Canada territory managers, supported by a Scientific Director, PhD-level Scientific Product Managers, and a Senior Scientific Liaison, provide application support that anchors the value proposition. As a privately held firm with no disclosed funding rounds, parent company, or subsidiaries, DiaPharma is owned and operated independently, with leadership under President and CEO Madeleine Burmester alongside CSO Michael Hambleton, PhD, CFO Tom Shannon, and Scientific Director Jennifer Kiblinger.
DiaPharma firmographics
Firmographics- Name
- DiaPharma
- Legal name
- DiaPharma Group, Inc.
- Website
- https://diapharma.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DiaPharma is a privately held US/Canadian specialty distributor of hemostasis, coagulation, liver disease, hematology, and biomarker assay kits and instruments from 18+ partner brands, serving clinical and research laboratories since 1997.
- Ownership category
- akta.pro rank
DiaPharma industry classification
Industry- Product category
- Specialty Diagnostics Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)
- akta.pro secondary industries
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)
Keywords
Where DiaPharma is headquartered
LocationHeadquarters
- HQ city
- West Chester
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
DiaPharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D
Revenue model
- Diagnostic Assay Kits: Sale of specialty research and clinical assay kits including hemostasis tests, liver disease biomarkers, and coagulation assays. Products sold under various brands including their own DPG label and distributed partner brands.
- Laboratory Instruments: Sale and distribution of hemostasis analyzers and instruments including Ceveron series, T-TAS systems, Atlas PST, and related accessories and consumables.
- Reagents and Consumables: Sale of specialty reagents including deficient plasmas, calibrators, controls, substrates, and antibodies for research and clinical testing applications.
- Distribution Rights: DiaPharma serves as exclusive US and Canadian distributor for Chromogenix products and distributes products from multiple partner brands including Technoclone, Haematex, Volition, VLVbio/Peviva, and others.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
DiaPharma product offering
Product offeringCore offering
DiaPharma is a specialty distributor of research and clinical assay kits, bioreagents, antibodies, and instruments focused on hemostasis, coagulation, platelet function, liver disease, cell death, and toxicology. The company distributes products under its own DPG label and as the exclusive US and Canadian distributor for Chromogenix, Technoclone, Haematex, VLVbio/Peviva, Volition, Zacros, QuickZyme, Rossix, and other partner brands, providing personalized scientific expertise and customer support to clinical and research laboratories.
Product overview
DiaPharma is a specialty research and clinical assay kit and instrumentation distributor operating in the United States and Canada. The company offers a comprehensive portfolio organized into seven core product categories: Hemostasis (365+ products including coagulation assays, chromogenic substrates, and specialty reagents), Instruments (66 products including Ceveron® s100, T-TAS® 01, Atlas PST, and Ceveron® m Series analyzers), Hematology (flow cytometry antibodies for sickle cell and fetomaternal hemorrhage research), Liver Disease (CK18 biomarker assays including M30 Apoptosense®, M65®, M65 EpiDeath®, and L-FABP/FGF ELISA kits), Fibrosis (QuickZyme collagen and MMP activity assay kits), NETosis Research (Volition Nu Q® Discover H3.1 nucleosome ELISAs), and Additional Biomarkers (covering oncology, kidney, diabetes, and infectious disease). The products are distributed from multiple brand partners including Technoclone, Chromogenix, VLVbio/Peviva, QuickZyme, Rossix, Haematex, Zacros, Teco Medical, Pplus, and others. DiaPharma provides specialty diagnostic and research tools with technical and customer support for hemostasis/special coagulation, cell death, and toxicology needs.
Differentiator
Problem solved
Functional benefit
Products and services
- Hemostasis Products Specialty research and clinical assay kits for hemostasis testing covering TTP, Hemophilia, Thrombophilia, anticoagulation measurement, antiphospholipid antibody, bleeding disorders, chromogenic substrates, fibrinolysis, global hemostasis assays, TMAs/TTP, and thrombophilia. Includes 365+ products for clinical and research laboratories.
- Instruments Primary and secondary hemostasis instruments and accessories including Ceveron s100, T-TAS 01, Atlas PST, Thrombodynamics, Ceveron m Series, and Ceveron MFU500 analyzers for coagulation testing and platelet function testing.
- Hematology Products Flow cytometry antibodies for identifying, quantifying, and characterizing different types of blood cells and abnormalities, including products for fetomaternal hemorrhage (FMH) research and sickle cell research.
- Liver Disease Products Research tools for liver disease including ALD/AH, DILI/Hepatotoxicity, MASLD/MASH (NAFLD/NASH) biomarker assays such as M30 Apoptosense CK18 Kit, M65 ELISA CK18 Kit, M65 EpiDeath CK18 Kit, L-FABP ELISA, and FGF-19/21 ELISA kits.
- Fibrosis Products Assay kits and reagents for fibrosis research including QuickZyme MMP-14, MMP-2, MMP-7, MMP-8, MMP-9 activity assay kits, hydroxyproline assay kits, and sensitive/total/soluble collagen assay kits.
- NETosis Research Products ELISA kits for NETosis research including Volition Nu Q Discover H3.1 ELISA for measuring neutrophil extracellular traps (NETs) in research applications.
- Additional Biomarkers Products Biomarker assay kits covering bone metabolism, diabetes, ecotoxicology, kidney, oncology, pulmonary, and transplantation/infectious disease including AroCell TK210 ELISA, TECO Urine Stabilizing Tubes, NGAL ELISA, and CMV Brite Turbo Kit.
Companies that use DiaPharma
Customer profileSegments5 records
Ideal customer profiles4 records
DiaPharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
DiaPharma partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core and minor.
- ChromogenixcoreDiaPharma is the exclusive US and Canadian distributor for Chromogenix hemostasis and fibrinolysis products. Chromogenix developed the first chromogenic peptide substrate S-2160 in the early 1970s and offers over 30 products including chromogenic substrates and complete assay kits for hospitals, clinical laboratories, blood banks, and pharmaceutical testing. Products are manufactured by Instrumentation Laboratory in the US.
- TechnoclonecoreTechnoclone is a world-leading producer of ELISA systems, global and special coagulation tests, control and reference plasmas, and protein diagnostics. Founded in 1987 by Prof. Dr. Bernd Binder, the company specializes in monoclonal antibodies against coagulation and fibrinolysis system components. DiaPharma distributes Technoclone products including Ceveron automated analyzers, Technozym ELISA kits, and Technothrombin TGA kits.
- HaematexcoreHaematex Research, founded by Dr. Thomas Exner, specializes in blood coagulation methods with decades of experience. Dr. Exner developed the dilute Russell Viper Venom Test (dRVT) widely used for detecting lupus anticoagulants. Products include DOAC-Stop tablets/liquid for DOAC neutralization, inhibitor tubes, and XACT test for hypercoagulability assessment.
- VLVbio (Peviva)coreVLVbio owns the Peviva brand of cell death (apoptosis and necrosis) ELISAs and antibodies, established in Stockholm, Sweden in 2013. The M30 Apoptosense ELISA, M65 ELISA, and M65 EpiDeath ELISA are registered with the Swedish Medical Products Agency (CE-IVD). DiaPharma distributes Peviva products in the US and Canada.
- VolitioncoreVolition develops NETosis biomarker assays including the Nu Q Discover H3.1 ELISA for measuring neutrophil extracellular traps (NETs). DiaPharma distributes Volition products for NETosis research in the US and Canada market.
- ZacroscoreZacros (Fujimori Kogyo Co., Ltd., Tokyo, Japan) produces the T-TAS (Total Thrombus-formation Analysis System), a microfluidic flow chamber system for physiological platelet function testing. Zacros is ISO 9001:2008 and ISO 14001:2004 certified. DiaPharma distributes T-TAS products including AR Chip and HD Chip consumables.
- QuickZymeminorQuickZyme Biosciences develops assays for collagen analysis including soluble collagen, total collagen, and MMP activity assays. Products are colorimetric-based with 96-well plate format, applicable for tissue samples from any species.
- RossixminorRossix specializes in hemostasis products with over 30 years of development experience. Provides chromogenic activity and ELISA assays for Factor VIII, X, IX, VII, V, II, and Protein C. Performs contract analyses and serves as reference center in WHO calibration studies.
- StasysminorStasys Medical produces the Atlas PST (Platelet Strength Test) for platelet micro force generation and aggregometry testing. DiaPharma distributes Stasys products in the US and Canada.
- Teco MedicalminorSwiss-based TECOmedical Group with subsidiaries in Germany, France, and Benelux provides in-vitro specialty test systems for medical diagnostics, biosafety, and environmental testing. Products include intact proinsulin ELISA for diabetes research.
- PplusminorPplus Medical Limited (Ireland) specializes in regenerative medicine using advanced Platelet Rich Plasma (PRP) technology. Products include Digital Storage Device (DSD) for platelet storage, sterile ampoules, and Collagen-Related Peptide-A (CRP-A).
- AroCellminorAroCell produces TK210 Thymidine Kinase 1 ELISA kit for oncology research applications.
- ImmunoDiagnostics Limited (IMD)minorIMD is a spin-off from University of Hong Kong with R&D in Toronto, Canada and Hong Kong. Specializes in biomarker discovery and development of immunoassays for infectious diseases, cardiometabolic disorders, and autoimmune diseases. Products include FGF-19 and FGF-21 ELISA kits.
- IQ ProductsminorIQ Products provides hematology research tools including Fetal Cell Count kit and hemoglobin monoclonal antibodies (Anti-HbF, Anti-HbS, Anti-pan hemoglobin) for sickle cell research and fetomaternal hemorrhage detection.
- ProAxsisminorProAxsis produces NEATstik rapid neutrophil elastase activity tests and ProteaseTag immunoassays for active proteinase detection, used in pulmonary and ecotoxicology research.
- BioTekminorBioTek Instruments (Vermont-based) manufactures microplate instrumentation and bio-analytics software for life science research. Products include detection, washing, liquid dispensing, and automation systems for microplate formats used in screening and measurement.
- CMICminorCMIC produces L-FABP (FABP1) ELISA kits for liver and intestinal fatty acid binding protein detection in research applications.
- Inter-ArrayminorInter-Array provides von Willebrand Factor Propeptide (vWF:PP) ELISA test kits for research use.
Scale indicators3 records
Recent moves8 records
Expansion highlights5 records
DiaPharma competitors and assessment
Company assessmentDirect peers
- Diagnostica Stago: Specialty coagulation and hemostasis diagnostics manufacturer with deep expertise in thrombin generation, platelet function, and factor assays — the most direct global competitor to DiaPharma's Chromogenix/Technoclone-based hemostasis portfolio.
- Helena Laboratories: Specialty distributor and manufacturer of hemostasis, electrophoresis, and clinical chemistry products with overlapping coagulation and platelet function offerings sold through US specialty channels similar to DiaPharma's go-to-market.
- Precision BioLogic: Canadian specialty coagulation diagnostics company developing and selling hemostasis reagents and controls — a direct regional competitor sharing the US/Canada specialty lab customer base with DiaPharma.
- Hyphen BioMed (Sysmex): Specialty hemostasis and thrombosis reagent manufacturer now part of Sysmex, offering ELISA and chromogenic assay kits that directly overlap with DiaPharma's Technoclone, Chromogenix, and Rossix product lines.
Broad incumbents
- Instrumentation Laboratory (Werfen): Manufactures the Chromogenix product line that DiaPharma distributes; operates the ACL TOP family of hemostasis analyzers and a broad hemostasis/reagent portfolio across North America as both an upstream supplier and a competing direct distributor.
- Bio-Rad Laboratories: Major life science and clinical diagnostics company with broad reagent and instrument portfolios that overlap DiaPharma's hemostasis, ELISA, and clinical chemistry offerings at significantly larger scale.
- Siemens Healthineers: Operates a broad hemostasis/coagulation portfolio (Sysmex CA-series analyzers originally via Siemens) and INNOVANCE reagent line, competing with DiaPharma's distributed Chromogenix and Technoclone coagulation assays at hospitals and reference labs.
- Haemonetics: Blood and plasma management company with platelet function testing products (VerifyNow) overlapping DiaPharma's platelet function and T-TAS offerings across hospital and specialty lab customers.
- Sekisui Diagnostics: Broad in vitro diagnostics company with coagulation, clinical chemistry, and specialty reagents that overlap DiaPharma's hemostasis and specialty diagnostic kit portfolio across US lab and hospital channels.
Emerging players
- R2 Diagnostics: Smaller specialty coagulation controls and reagents supplier with a focused hemostasis portfolio comparable to DiaPharma's specialty reagent/control business, often competing for the same specialty lab budget.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
DiaPharma social profiles
Digital presenceDiaPharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
DiaPharma leadership team
Management profileNumber of profiles
Profiles15 records
DiaPharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DiaPharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DiaPharma
What does DiaPharma do?
DiaPharma is a specialty distributor of research and clinical assay kits, bioreagents, antibodies, and instruments focused on hemostasis, coagulation, platelet function, liver disease, cell death, and toxicology. The company distributes products under its own DPG label and as the exclusive US and Canadian distributor for Chromogenix, Technoclone, Haematex, VLVbio/Peviva, Volition, Zacros, QuickZyme, Rossix, and other partner brands, providing personalized scientific expertise and customer support to clinical and research laboratories.
Is DiaPharma a public or private company?
DiaPharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DiaPharma founded?
DiaPharma was founded in 1997. It employs 11 to 50 people.
Where is DiaPharma based?
DiaPharma is headquartered in West Chester, United States, in the North America region.
How does DiaPharma make money?
Four revenue lines are on record. Diagnostic Assay Kits are the primary driver. The others are laboratory Instruments, reagents and Consumables and distribution Rights.
Who are DiaPharma's main competitors?
Direct peers on record are Diagnostica Stago, Helena Laboratories, Precision BioLogic and Hyphen BioMed (Sysmex). Broad incumbents are Instrumentation Laboratory (Werfen), Bio-Rad Laboratories, Siemens Healthineers, Haemonetics and Sekisui Diagnostics. R2 Diagnostics is listed as an emerging player.
Does DiaPharma have an API?
No public API is recorded for DiaPharma.
What industry is DiaPharma in?
DiaPharma's product category is Specialty Diagnostics Distribution. Its primary akta.pro industry code is HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 424210 and its SIC code is 5122.